Humacyte (HUMA) Capital Expenditures (2020 - 2026)
Humacyte (HUMA) reported Capital Expenditures of $104,000 for Q2 2026, down 81.7% from $568,000 a year earlier and down 40.6% from the prior quarter.
Powered by 
Analysis
Humacyte (HUMA) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Humacyte's Capital Expenditures came in at $367,000, down 79.5% year-over-year; for FY2025, it came in at $884,000, down 43.8% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.57 million in FY2024 (-31.1%), $2.28 million in FY2023 (+117.6%), $1.05 million in FY2022 (+376.4%) and $220,000 in FY2021 (-30.8%).
- Five-year quarterly Capital Expenditures spans a low of $22,000 in Q1 2022 and a high of $1.15 million in Q1 2023.
- Year over year, Capital Expenditures has now declined in each of the last four quarters, with an average decline of 4.9% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q2 2023 (growth of 261.9%); the low point was Q3 2025 (a decline of 94.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $175,000 (Q1 2026), $39,000 (Q4 2025) and $49,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Humacyte | 163.90 Mn | -213.24 Mn | -401,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 104,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 39,000.00 |
| Sep 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 568,000.00 |
| Mar 31, 2025 | 228,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 934,000.00 |
| Jun 30, 2024 | 184,000.00 |
| Mar 31, 2024 | 391,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Sep 30, 2023 | 493,000.00 |
| Jun 30, 2023 | 485,000.00 |
| Mar 31, 2023 | 1.15 Mn |
| Jun 30, 2022 | 134,000.00 |
| Mar 31, 2022 | 22,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 83,000.00 |
| Jun 30, 2021 | 63,000.00 |
| Mar 31, 2021 | 29,000.00 |
API Access
Humacyte Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HUMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "HUMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=HUMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();